Goodness Growth Holdings Inc (OTCQX International:GDNSF)
| 0.1699 Delayed Data As of Feb 01 |  -0.0001 / -0.06%Today’s Change | 0.14 Today|||52-Week Range 2.65 | +6.19% Year-to-Date |
| SECTOR Process Industries | INDUSTRY Agricultural Commodities/Milling | MARKET CAP $14.3M |
Company Description
Goodness Growth Holdings, Inc. is a holding company, which engages in the cultivation, production, and sale of medical cannabis. It manufactures and package cannabis finished goods across a variety of product segments: Inhalable, Ingestible and Topicals. The Inhalable product segment includes flower and trim, dabbable concentrates (e.g., Hash, Rosin, Temple Balls), distillate pre-filled vaporizer pens and cartridges, pre-rolls, distillate syringes. The Ingestible product segment includes edibles, tablets, softgels, oral solutions, oral spray, tinctures, lozenges. The Topicals product segment includes balms and topical bars. The company was founded by Kyle E. Kingsley on November 23, 2004 and is headquartered in Minneapolis, MN.
Contact Information
Goodness Growth Holdings, Inc. 207 South 9th Street Minneapolis Minnesota 55402 |
Employees
Shareholders
| Mutual fund holders | -- |
| Individual stakeholders | -- |
| Other institutional | -- |
Top Executives
| Kyle E. Kingsley | Chairman & Chief Executive Officer |
| Joshua N. Rosen | President & Director |
| John Andrew Heller | Chief Financial Officer |
| Stephen Dahmer | Chief Medical Officer |
| Eric Greenbaum | Chief Scientific Officer |
